243 related articles for article (PubMed ID: 35842684)
1. One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
Shi L; Zheng Y; Cheng Z; Ji N; Niu C; Wang Y; Huang T; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
Stem Cell Res Ther; 2022 Jul; 13(1):321. PubMed ID: 35842684
[TBL] [Abstract][Full Text] [Related]
2. Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge.
Feng G; Shi L; Huang T; Ji N; Zheng Y; Lin H; Niu C; Wang Y; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J
Stem Cells Dev; 2021 Aug; 30(15):773-781. PubMed ID: 34044609
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
[TBL] [Abstract][Full Text] [Related]
6. Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up.
Zhang C; Huang L; Wang X; Zhou X; Zhang X; Li L; Wu J; Kou M; Cai C; Lian Q; Zhou X
Stem Cell Res Ther; 2022 Sep; 13(1):451. PubMed ID: 36064461
[TBL] [Abstract][Full Text] [Related]
7. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
[TBL] [Abstract][Full Text] [Related]
9. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study.
Yang Y; Cao TT; Tian ZM; Gao H; Wen HQ; Pang M; He WJ; Wang NX; Chen YY; Wang Y; Li H; Lin JW; Kang Z; Li MM; Liu B; Rong LM
Exp Cell Res; 2020 Oct; 395(2):112184. PubMed ID: 32707134
[TBL] [Abstract][Full Text] [Related]
10. Human Umbilical Cord Mesenchymal Stem Cells' Cultivation and Treatment of Liver Diseases.
Zhu Z; Zhang Q; Liu L; Xu J
Curr Stem Cell Res Ther; 2023; 18(3):286-298. PubMed ID: 35747963
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats.
Fahmy SR; Soliman AM; El Ansary M; Elhamid SA; Mohsen H
Tissue Cell; 2017 Jun; 49(3):369-375. PubMed ID: 28476205
[TBL] [Abstract][Full Text] [Related]
13. [Protective Effects of Intraventricular Transplanted Human Umbilical Cord-derived Mesenchymal Stem Cells on Hypoxic Ischemic Brain Damages in Rats].
Fan X; Bai XH; Chen J; Wan Q; Chen Q; Mu DZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):179-185. PubMed ID: 28612523
[TBL] [Abstract][Full Text] [Related]
14. Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells.
Chin SP; Saffery NS; Then KY; Cheong SK
In Vitro Cell Dev Biol Anim; 2024 Mar; 60(3):307-319. PubMed ID: 38421574
[TBL] [Abstract][Full Text] [Related]
15. Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue.
Gao S; Jin Y; Ma J; Wang J; Wang J; Shao Z; Fan T; Zhang M; Chang D
Stem Cell Res Ther; 2022 Jun; 13(1):252. PubMed ID: 35690871
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China.
Huang L; Zou J; Zhang Y; Gu J; Wu J; Zhang C
BMJ Open; 2024 Mar; 14(3):e075138. PubMed ID: 38490657
[TBL] [Abstract][Full Text] [Related]
17. Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats.
Chou HC; Chang CH; Chen CH; Lin W; Chen CM
Stem Cell Res Ther; 2021 May; 12(1):258. PubMed ID: 33933128
[TBL] [Abstract][Full Text] [Related]
18. Effect of Human Umbilical Cord Matrix-Derived Mesenchymal Stem Cells on Bisphosphonate-Related Osteonecrosis of the Jaw.
Yang G; Kim YN; Kim H; Lee BK
Tissue Eng Regen Med; 2021 Dec; 18(6):975-988. PubMed ID: 34347277
[TBL] [Abstract][Full Text] [Related]
19. Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells.
Hernandez JJ; Beaty DE; Fruhwirth LL; Lopes Chaves AP; Riordan NH
J Transl Med; 2021 Apr; 19(1):149. PubMed ID: 33853637
[TBL] [Abstract][Full Text] [Related]
20. Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34⁺ cells in a rabbit model of myocardial infarction.
Li T; Ma Q; Ning M; Zhao Y; Hou Y
Mol Cell Biochem; 2014 Feb; 387(1-2):91-100. PubMed ID: 24166198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
